摘要
亚临床房颤(subclinical atrial fibrillation,SCAF)是指没有或几乎没有症状,以亚临床形式发生,通过对心脏植入式电子装置(cardiac implantable electronic devices,CIED)进行程控而发现的房颤。近些年,随着CIED的发展,SCAF逐渐被学者们所认识,并成为研究的焦点。本文主要对SCAF的筛查手段、脑卒中风险、治疗方法等方面的最新进展进行综述。
Subclinical atrial fibrillation(SCAF)refers to atrial fibrillation with no or almost no symptoms which occurs in a subclinical form.It is detected by the programming of cardiac implantable electronic devices(CIED).In recent years,with the development of CIED,SCAF has gradually been recognized by scholars,and become the focus of research.This article mainly reviews the latest progress in aspects of screening methods,risk of stroke and therapy of SCAF.
作者
优里吐孜·阿地里
苏比努尔·阿布力米提
姚娟
高洁
ADILI Youlituzi;ABULIMITI Subinuer;YAO Juan;GAO Jie(Graduate School,Xinjiang Medical University;Department of Cardiology,the Peoples Hospital of Xinjiang Uygur Autonomous Region,Urumqi Xinjiang 830001,China)
出处
《实用心电学杂志》
2023年第1期52-55,共4页
Journal of Practical Electrocardiology
基金
自治区区域协同创新专项(科技援疆计划)(2021E02076)。
关键词
亚临床房颤
脑卒中
心房高频事件
心脏植入式器械
抗凝治疗
机会性筛查
subclinical atrial fibrillation
stroke
atrial high-rate event
cardiac implantable device
anticoagulant therapy
opportunistic screening
